cefoxitin and Diabetes-Mellitus--Type-1

cefoxitin has been researched along with Diabetes-Mellitus--Type-1* in 2 studies

Other Studies

2 other study(ies) available for cefoxitin and Diabetes-Mellitus--Type-1

Article	Year
Recurrent infection of continuous subcutaneous insulin infusion sites with Mycobacterium fortuitum. Diabetes care, 1995, Volume: 18, Issue:9 Topics: Anti-Bacterial Agents; Blood Glucose; Cefoxitin; Ciprofloxacin; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Glycated Hemoglobin; Humans; Injections, Subcutaneous; Insulin; Minocycline; Mycobacterium Infections; Recurrence	1995
Serum sickness associated with cefoxitin and pentoxifylline therapy. Drug intelligence & clinical pharmacy, 1986, Volume: 20, Issue:12 Human serum sickness is a syndrome characterized by fever, malaise, skin rashes, arthralgias, gastrointestinal disturbances, and lymphadenopathy. It is believed to be mediated by circulating immune complexes composed of a foreign antigen and host antibody. Several cephalosporins have been associated with serum sickness. We report the occurrence of serum sickness in a patient who received cefoxitin, a commonly used cephamycin antibiotic, and pentoxifylline, a xanthine derivative that improves the flow properties of blood by decreasing its viscosity. Serum sickness has not been previously reported with the use of cefoxitin or pentoxifylline. Topics: Cefoxitin; Diabetes Mellitus, Type 1; Drug Interactions; Humans; Male; Middle Aged; Pentoxifylline; Serum Sickness; Theobromine	1986

Article

Year

Recurrent infection of continuous subcutaneous insulin infusion sites with Mycobacterium fortuitum.

Diabetes care, 1995, Volume: 18, Issue:9

Topics: Anti-Bacterial Agents; Blood Glucose; Cefoxitin; Ciprofloxacin; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Glycated Hemoglobin; Humans; Injections, Subcutaneous; Insulin; Minocycline; Mycobacterium Infections; Recurrence

1995

Serum sickness associated with cefoxitin and pentoxifylline therapy.

Drug intelligence & clinical pharmacy, 1986, Volume: 20, Issue:12

Human serum sickness is a syndrome characterized by fever, malaise, skin rashes, arthralgias, gastrointestinal disturbances, and lymphadenopathy. It is believed to be mediated by circulating immune complexes composed of a foreign antigen and host antibody. Several cephalosporins have been associated with serum sickness. We report the occurrence of serum sickness in a patient who received cefoxitin, a commonly used cephamycin antibiotic, and pentoxifylline, a xanthine derivative that improves the flow properties of blood by decreasing its viscosity. Serum sickness has not been previously reported with the use of cefoxitin or pentoxifylline.

Topics: Cefoxitin; Diabetes Mellitus, Type 1; Drug Interactions; Humans; Male; Middle Aged; Pentoxifylline; Serum Sickness; Theobromine

1986